|
RPL28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5501799999984E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.952600E-04 |
| Normal-vs-Stage2 |
1.016350E-01 |
| Normal-vs-Stage3 |
1.55321999999458E-05 |
| Normal-vs-Stage4 |
6.03809999999427E-05 |
| Stage1-vs-Stage2 |
2.163400E-01 |
| Stage1-vs-Stage3 |
1.184120E-02 |
| Stage1-vs-Stage4 |
3.761900E-02 |
| Stage2-vs-Stage3 |
9.056400E-03 |
| Stage2-vs-Stage4 |
1.324100E-02 |
| Stage3-vs-Stage4 |
9.471600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52835999999157E-05 |
| Normal-vs-AfricanAmerican |
1.120730E-03 |
| Normal-vs-Asian |
7.753100E-04 |
| Caucasian-vs-AfricanAmerican |
2.426600E-01 |
| Caucasian-vs-Asian |
4.160200E-01 |
| AfricanAmerican-vs-Asian |
6.838800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22909999999521E-05 |
| Normal-vs-Female |
4.23700000000693E-05 |
| Male-vs-Female |
2.636400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.042500E-04 |
| Normal-vs-Age(41-60Yrs) |
4.363900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.046780E-04 |
| Normal-vs-Age(81-100Yrs) |
7.581000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.976600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.819200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.843400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.157030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.229900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.687200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.236200E-01 |
| Classical-VS-Follicular |
5.166300E-04 |
| Classical-VS-Other |
1.231970E-02 |
| Classical-VS-Normal |
1.28889999995163E-06 |
| Tall-VS-Follicular |
1.947520E-02 |
| Tall-VS-Other |
1.905830E-02 |
| Tall-VS-Normal |
1.564990E-03 |
| Follicular-VS-Other |
5.849000E-01 |
| Follicular-VS-Normal |
9.235900E-02 |
| Other-VS-Normal |
3.824800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.69240000000337E-05 |
| Normal-vs-N1 |
9.159100E-04 |
| N0-vs-N1 |
7.374200E-01 |
|
|
